Actinobacteria Metabolic Engineering


This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)

The growing resistance towards established antibiotics presents a serious problem especially with infectious diseases. The development of new drugs is mainly based on known molecules and mechanisms, which allows bacteria to assimilate rapidly. Hence, scientists are looking for novel drugs. At the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a branch of the Helmholtz Centre for Infection Research (HZI) at Braunschweig, the researchers develop new pathways, by which they force actinomycetes to produce hitherto unknown compounds.

Leader

Team

Dr Andriy Luzhetskyy

Head of Junior Research Group Actinobacteria Metabolic Engineering

Bachelor & Master
Are you interested in a bachelor or master thesis? We are looking forward to your request!

Video

  • HIPS Infofilm (English)

    Resistance to antibiotics has become one of the major global challenges regarding infectious diseases. This is specifically the issue that is being tackled by the new Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS).

PrintSend per emailShare